Join to access to all OVN content. Join for Free
Be Brave-A Networking Tale that Led to Friendship
authentic networking LinkedIn connections overcoming networking fear building genuine connections networking communication skills altruism in networking networking courage

Be Brave-A Networking Tale that Led to Friendship


Share This Article


Summary

In this episode, Josh Yoder and Kirsten Borbe to share their amazing story of how a networking message on LinkedIn led to a friendship. The discussion begins with insights into Josh and Kirsten's backgrounds and networking perspectives. They emphasize the importance of authentic networking and overcoming fear, sharing strategies for building genuine connections and evolving professional relationships into friendships. Key communication skills such as brevity and authenticity are highlighted, alongside the role of altruism in networking. The conversation addresses the fear of risk and concludes with thoughts on networking courage and bravery. Closing remarks offer appreciation for the insights shared.

Key Points

  • Networking should be approached with authenticity and a genuine interest in others, rather than self-promotion.
  • Building meaningful connections often involves taking risks and embracing opportunities, even if it means stepping out of your comfort zone.
  • The real value in networking comes from helping others without expecting anything in return, which often leads to more fulfilling and long-lasting relationships.

Click for Source
authentic networking, LinkedIn connections, overcoming networking fear, building genuine connections, networking communication skills, altruism in networking, networking courage

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Where Did My Interview Go Wrong?
Partner Avatar Tom Caravela

Where Did My Interview Go Wrong?

Article
Expert perspectives live from ASCO® 2025
Partner Avatar iNIZIO

Expert perspectives live from ASCO® 2025

Article
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
OVN Avatar Laleh Amiri-Kordestani & Richard Pazdur

Oncology approvals in 2020: a year of firsts in the midst of a pandemic

Article
Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities
OVN Avatar Nidal Al-Huniti, Yan Feng, Jingyu (Jerry) Yu, Zheng Lu, Mario Nagase, Diansong Zhou, Jennifer Sheng

Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities

Article
Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2
OVN Avatar Guillaume Beinse, MD, Virgile Tellier, Valentin Charvet, MSc, Eric Deutsch, MD, PhD, Isabelle Borget, PharmD, PhD, Christophe Massard, MD, PhD., Antoine Hollebecque, MD, PhD, and Loic Verlingue, MD

Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2

Article
Accelerated drug approvals in oncology: Pros and cons
OVN Avatar Thakur, Sayanta & Lahiry, Sandeep

Accelerated drug approvals in oncology: Pros and cons

Explore OVN